Iguana Healthcare Management as of March 31, 2015
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 62 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pfizer (PFE) | 8.8 | $21M | 600k | 34.79 | |
| Esperion Therapeutics (ESPR) | 7.8 | $19M | 200k | 92.60 | |
| Celgene Corporation | 5.3 | $13M | 110k | 115.28 | |
| Ultragenyx Pharmaceutical (RARE) | 4.6 | $11M | 175k | 62.09 | |
| Gilead Sciences (GILD) | 4.1 | $9.8M | 100k | 98.13 | |
| Actavis | 3.1 | $7.4M | 25k | 297.64 | |
| Acceleron Pharma | 2.8 | $6.7M | 175k | 38.06 | |
| iShares Russell 2000 Index (IWM) | 2.6 | $6.2M | 50k | 124.38 | |
| Supernus Pharmaceuticals (SUPN) | 2.5 | $6.0M | 500k | 12.09 | |
| Puma Biotechnology (PBYI) | 2.5 | $5.9M | 25k | 236.12 | |
| Zimmer Holdings (ZBH) | 2.5 | $5.9M | 50k | 117.52 | |
| Accelr8 Technology | 2.4 | $5.6M | 250k | 22.50 | |
| Endo International | 2.3 | $5.4M | 60k | 89.70 | |
| Humana (HUM) | 2.2 | $5.3M | 30k | 178.03 | |
| Express Scripts Holding | 2.2 | $5.2M | 60k | 86.77 | |
| Horizon Pharma | 2.2 | $5.2M | 200k | 25.97 | |
| St. Jude Medical | 2.1 | $4.9M | 75k | 65.40 | |
| Gw Pharmaceuticals Plc ads | 1.9 | $4.6M | 50k | 91.14 | |
| WellCare Health Plans | 1.7 | $4.1M | 45k | 91.47 | |
| Tornier Nv | 1.6 | $3.9M | 150k | 26.22 | |
| CIGNA Corporation | 1.6 | $3.9M | 30k | 129.43 | |
| Aerie Pharmaceuticals | 1.6 | $3.8M | 120k | 31.34 | |
| Cardinal Health (CAH) | 1.5 | $3.6M | 40k | 90.28 | |
| Impax Laboratories | 1.5 | $3.5M | 75k | 46.87 | |
| Cymabay Therapeutics | 1.5 | $3.5M | 500k | 6.92 | |
| Novadaq Technologies | 1.4 | $3.2M | 200k | 16.24 | |
| Medivation | 1.4 | $3.2M | 25k | 129.08 | |
| Aratana Therapeutics | 1.4 | $3.2M | 200k | 16.01 | |
| Anthem (ELV) | 1.3 | $3.1M | 20k | 154.40 | |
| Merck & Co (MRK) | 1.2 | $2.9M | 50k | 57.48 | |
| Celldex Therapeutics | 1.2 | $2.8M | 100k | 27.87 | |
| Tetraphase Pharmaceuticals | 1.2 | $2.7M | 75k | 36.64 | |
| Ligand Pharmaceuticals In (LGND) | 1.1 | $2.7M | 35k | 77.11 | |
| Wright Medical | 1.1 | $2.6M | 100k | 25.80 | |
| Dyax | 1.1 | $2.5M | 150k | 16.75 | |
| Abbott Laboratories (ABT) | 1.0 | $2.3M | 50k | 46.34 | |
| Abbvie (ABBV) | 1.0 | $2.3M | 50k | 46.34 | |
| Flamel Technologies | 0.9 | $2.2M | 125k | 17.98 | |
| HCP | 0.9 | $2.2M | 50k | 43.22 | |
| Immune Design | 0.9 | $2.1M | 100k | 21.11 | |
| Neurocrine Biosciences (NBIX) | 0.8 | $2.0M | 50k | 39.72 | |
| Assembly Biosciences | 0.8 | $2.0M | 150k | 13.24 | |
| Spectranetics Corporation | 0.7 | $1.7M | 50k | 34.76 | |
| IPC The Hospitalist Company | 0.7 | $1.6M | 35k | 46.63 | |
| Castlight Health | 0.7 | $1.6M | 200k | 7.76 | |
| Ptc Therapeutics I (PTCT) | 0.6 | $1.5M | 25k | 60.84 | |
| EnteroMedics | 0.6 | $1.3M | 1.4M | 0.91 | |
| Dermira | 0.5 | $1.2M | 80k | 15.35 | |
| Therapeuticsmd | 0.5 | $1.2M | 200k | 6.05 | |
| Kindred Healthcare | 0.5 | $1.2M | 50k | 23.80 | |
| Haemonetics Corporation (HAE) | 0.5 | $1.1M | 25k | 44.92 | |
| Flexion Therapeutics | 0.5 | $1.1M | 50k | 22.52 | |
| Nektar Therapeutics (NKTR) | 0.5 | $1.1M | 100k | 11.00 | |
| Dbv Technologies S A | 0.4 | $1.1M | 45k | 23.36 | |
| Pacific Biosciences of California (PACB) | 0.4 | $876k | 150k | 5.84 | |
| Endologix | 0.4 | $854k | 50k | 17.08 | |
| OraSure Technologies (OSUR) | 0.3 | $687k | 105k | 6.54 | |
| DepoMed | 0.2 | $560k | 25k | 22.40 | |
| Tesaro | 0.2 | $574k | 10k | 57.40 | |
| Tetrelogic Pharmaceuticals (TLOG) | 0.2 | $438k | 100k | 4.38 | |
| Mei Pharma | 0.1 | $269k | 150k | 1.79 | |
| Immunomedics | 0.1 | $192k | 50k | 3.84 |
